This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Gulesi Ayanoglu: Innovator in Immunoassay Technology
Introduction
Gulesi Ayanoglu is a notable inventor based in Palo Alto, CA (US). He has made significant contributions to the field of immunoassays, particularly in the detection and quantification of soluble PD-L1. His work is essential for advancing diagnostic techniques in various medical applications.
Latest Patents
Ayanoglu holds a patent for an "Immunoassay for soluble PD-L1." This patent describes two matched antibody pairs designed for use in a sandwich immunoassay. The immunoassay is optimized and validated with one of the matched pairs, allowing for accurate detection in liquid samples. He has 1 patent to his name.
Career Highlights
Gulesi Ayanoglu is currently employed at Merck Sharp & Dohme Corp., a leading global healthcare company. His role involves research and development in immunoassay technologies, contributing to innovative solutions in the medical field.
Collaborations
Ayanoglu has collaborated with notable colleagues, including Xiaoyan Du, Jr. and Vinita Gupta. These partnerships enhance the research and development efforts within his team, fostering innovation in their projects.
Conclusion
Gulesi Ayanoglu is a prominent figure in the field of immunoassays, with a focus on soluble PD-L1 detection. His contributions through patents and collaborations continue to impact the healthcare industry positively.